Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
21 hedge funds and large institutions have $3.46M invested in Ocean Biomedical, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 18 closing their positions.
598% more call options, than puts
Call options by funds: $286K | Put options by funds: $41K
27% less capital invested
Capital invested by funds: $4.77M → $3.46M (-$1.31M)
42% less funds holding
Funds holding: 36 → 21 (-15)
83% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 18
83% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$35.2K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$19.9K |
| 3 |
NA
Nordwand Advisors
Radnor,
Pennsylvania
|
+$2.14K |
| 4 |
AA
ACT Advisors
Asheville,
North Carolina
|
+$74 |
| 5 |
FFA
Farther Finance Advisors
San Francisco,
California
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$79.3K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$71K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$55.1K |
| 4 |
Millennium Management
New York
|
-$43.5K |
| 5 |
Jane Street
New York
|
-$42.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
26
Centiva Capital
New York
| – | -$21.7K | -17,800 | Closed |
|
|
VF
27
Virtu Financial
New York
| – | -$15K | -12,047 | Closed |
|
28
Mariner
Overland Park,
Kansas
| – | -$12.9K | -10,603 | Closed |
|
29
Russell Investments Group
London,
United Kingdom
| – | -$10.5K | -8,639 | Closed |
|
30
Mirae Asset Global ETFs Holdings
Causeway Bay,
Hong Kong
| – | -$5.96K | -4,881 | Closed |
|
31
RhumbLine Advisers
Boston,
Massachusetts
| – | -$1.07K | -876 | Closed |
|
32
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$932 | -764 | Closed |
|
33
Barclays
London,
United Kingdom
| – | -$583 | -478 | Closed |
|
34
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$545 | -447 | Closed |
|
35
Osaic Holdings
Scottsdale,
Arizona
| – | -$366 | -300 | Closed |
|
|
FIA
36
FNY Investment Advisers
New York
| – | -$214 | -200 | -25% |
|
37
New York State Common Retirement Fund
Albany,
New York
| – | -$112 | -92 | Closed |
|
OCEA Hedge Fund Activity: Q3 2024 in Review
21 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q3 2024, worth a combined $3.46M — down 27% from $4.77M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of OCEA and 3 opened new positions — a net loss of 15 holders — while 12 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $35.2K. The largest seller was Goldman Sachs, exiting entirely with an estimated $79.3K sold.
- 21 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q3 2024, down from 36 in Q2 2024.
- Funds reported $3.46M of Ocean Biomedical, Inc. Common Stock stock for Q3 2024, down 27% quarter-over-quarter.
- 3 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q3 2024 and 18 closed out, a net change of -15 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q3 2024 was Citadel Advisors, an estimated $35.2K added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q3 2024 was Goldman Sachs, an estimated $79.3K sold.
Based on aggregated 13F filings for Q3 2024.